Abstract
Due to the combined effects of international travel, climate change, and globalization, clinicians in Southern Europe are seeing a re-emergence of parasitic infections once thought to have been eradicated, which can often result in chronic illness, and thus present new diagnostic and therapeutic challenges. Here, we comment on two such parasitic protozoa, Trypanosoma cruzi and Plasmodium, and how modulation of the gut microbiota can provide exciting new possible therapeutic strategies in the treatment and prevention of Chagas disease and malaria.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40475-022-00275-4/MediaObjects/40475_2022_275_Fig1_HTML.png)
Similar content being viewed by others
References
Church DL. Major factors affecting the emergence and re-emergence of infectious diseases. Clin Lab Med. 2004;24(3):559–86, v.
Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol [Internet]. 2013;14(7):685–90. https://doi.org/10.1038/ni.2608.
Dheilly NM, Poulin R, Thomas F. Biological warfare: microorganisms as drivers of host–parasite interactions. Infect Genet Evol [Internet]. 2015;34:251–9. Available from: https://www.sciencedirect.com/science/article/pii/S1567134815001896
Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82–94.
Guarner J. Chagas disease as example of a reemerging parasite. Semin Diagn Pathol. 2019;36(3):164–9.
Antinori S, Galimberti L, Bianco R, Grande R, Galli M, Corbellino M. Chagas disease in Europe: a review for the internist in the globalized world. European Journal of Internal Medicine [Internet]. 2017;43:6–15. Available from: https://www.sciencedirect.com/science/article/pii/S0953620517301772
Lewis MD, Fortes Francisco A, Taylor MC, Burrell-Saward H, McLatchie AP, Miles MA, et al. Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Cell Microbiol. 2014;16(9):1285–300.
Silberstein E, Serna C, Fragoso SP, Nagarkatti R, Debrabant A. A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging. PLoS ONE. 2018;13(4):e0195879.
de Souza-Basqueira M, Ribeiro RM, de Oliveira LC, Moreira CHV, Martins RCR, Franco DC, et al. Gut dysbiosis in Chagas disease. A possible link to the pathogenesis. Front Cell Infect Microbiol. 2020;10:402.
Robello C, Maldonado DP, Hevia A, Hoashi M, Frattaroli P, Montacutti V, et al. The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole. PLoS ONE. 2019;14(2):e0212593.
McCall LI, Tripathi A, Vargas F, Knight R, Dorrestein PC, Siqueira-Neto JL. Experimental Chagas disease-induced perturbations of the fecal microbiome and metabolome. PLoS Negl Trop Dis. 2018;12(3):e0006344.
Duarte-Silva E, Morais LH, Clarke G, Savino W, Peixoto C. Targeting the gut microbiota in Chagas disease: what do we know so far? Front Microbiol. 2020;11:585857.
Duarte R, Silva AM, Vieira LQ, Afonso LCC, Nicoli JR. Trypanosoma cruzi: influence of predominant bacteria from indigenous digestive microbiota on experimental infection in mice. Exp Parasitol. 2005;111(2):87–96.
Bautista GCR, Torres Á. The inoculation of Lactobacillus casei in NIH mice induces a protective response against Trypanosoma cruzi (Ninoa strain) infection. Veterinaria México. 2008;39(2):139–44.
Martini M, Angheben A, Riccardi N, Orsini D. Fifty years after the eradication of malaria in Italy. The long pathway toward this great goal and the current health risks of imported malaria. Pathog Glob Health. 2021;115(4):215–23.
GregurićGracner G, Vucevac BV. History of eradication of malaria in Croatia. Orvostorteneti kozlemenyek. 2002;47(1–4):145–55.
Boccolini D, Menegon M, di Luca M, Toma L, Severini F, Marucci G, et al. Non-imported malaria in Italy: paradigmatic approaches and public health implications following an unusual cluster of cases in 2017. BMC Public Health. 2020;20(1):857.
European Centre for Disease Prevention and Control. Rapid risk assessment: multiple reports of locally-acquired malaria infections in the EU [Internet]. 2017. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-multiple-reports-locally-acquired-malaria-infections-eu
Panin F, Orlandini E, Galli L, de Martino M, Chiappini E. Increasing imported malaria in children and adults in Tuscany, Italy, (2000 to 2017): a retrospective analysis. Travel Med Infect Dis. 2019;29:34–9.
Garcia LS. Malaria. Clin Lab Med. 2010;30(1):93–129.
Guan W, Song X, Yang S, Zhu H, Li F, Li J. Observation of the gut microbiota profile in BALB/c mice induced by Plasmodium yoelii 17XL infection. Front Microbiol. 2022;13:858897.
Easton A v, Raciny-Aleman M, Liu V, Ruan E, Marier C, Heguy A, et al. Immune response and microbiota profiles during coinfection with Plasmodium vivax and soil-transmitted helminths. mBio. 2020;11(5):e01705-20.
Fan ZG, Li X, Fu HY, Zhou LM, Gong FL, Fang M. Gut microbiota reconstruction following host infection with blood-stage Plasmodium berghei ANKA strain in a murine model. Curr Med Sci. 2019;39(6):883–9.
Mutoni JD, Coutelier JP, Rujeni N, Mutesa L, Cani PD. Possible interactions between malaria, helminthiases and the gut microbiota: a short review. Microorganisms. 2022;10(4):721
Villarino NF, LeCleir GR, Denny JE, Dearth SP, Harding CL, Sloan SS, Gribble JL, Campagna SR, Wilhelm SW, Schmidt NW Composition of the gut microbiota modulates the severity of malaria. Proc Natl Acad Sci [Internet]. 2016;113(8):2235–40. https://doi.org/10.1073/pnas.1504887113.
Taniguchi T, Miyauchi E, Nakamura S, Hirai M, Suzue K, Imai T, et al. Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis. Sci Rep. 2015;5:15699.
Yooseph S, Kirkness EF, Tran TM, Harkins DM, Jones MB, Torralba MG, et al. Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infection. BMC Genomics [Internet]. 2015;16(1):631. https://doi.org/10.1186/s12864-015-1819-3.
Yilmaz B, Portugal S, Tran TM, Gozzelino R, Ramos S, Gomes J, et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell. 2014;159(6):1277–89.
Aguilar R, Ubillos I, Vidal M, Balanza N, Crespo N, Jiménez A, et al. Antibody responses to α-gal in African children vary with age and site and are associated with malaria protection. Sci Rep. 2018;8(1):9999.
Rodrigues da Cunha GM, Azevedo MA, Nogueira DS, de Clímaco MC, Valencia Ayala E, Jimenez Chunga JA, et al. α-gal immunization positively impacts Trypanosoma cruzi colonization of heart tissue in a mouse model. PLoS Negl Trop Dis. 2021;15(7):0009613.
Bamgbose T, Alberdi P, Abdullahi IO, Inabo HI, Bello M, Sinha S, et al. Functional characterization of α-gal producing lactic acid bacteria with potential probiotic properties. Sci Rep [Internet]. 2022;12(1):7484. https://doi.org/10.1038/s41598-022-11632-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Piazzesi, A., Pane, S. & Putignani, L. How Modulations of the Gut Microbiota May Help in Preventing or Treating Parasitic Diseases. Curr Trop Med Rep 9, 257–260 (2022). https://doi.org/10.1007/s40475-022-00275-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-022-00275-4